Paola Caramaschi

Summary

Publications

  1. doi request reprint Dramatic improvement of anti-SS-A/Ro-associated interstitial lung disease after immunosuppressive treatment
    Caramaschi Paola
    Unita di Reumatologia, AOUI, Policlinico G B Rossi, P le Scuro, 37134, Verona, Italy
    Rheumatol Int 36:1015-21. 2016
  2. doi request reprint Adherence to recommendations for cervical and breast cancer screening in systemic sclerosis
    P Caramaschi
    Rheumatology Unit, Department of Medicine, University of Verona
    Reumatismo 66:264-9. 2015
  3. doi request reprint Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis
    Paola Caramaschi
    Rheumatology Unit, University of Verona, Verona, Italy
    Clin Rheumatol 33:77-82. 2014
  4. doi request reprint The co-occurrence of Hashimoto thyroiditis in primary Sjogren's syndrome defines a subset of patients with milder clinical phenotype
    Paola Caramaschi
    Rheumatology Unit, Department of Medicine, University of Verona, Verona, Italy
    Rheumatol Int 33:1271-5. 2013
  5. doi request reprint Very low levels of vitamin D in systemic sclerosis patients
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    Clin Rheumatol 29:1419-25. 2010
  6. doi request reprint Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost
    Paola Caramaschi
    Rheumatology Unit, Department of Medicine, Piazzale Scuro, 37134 Verona, Italy
    Rheumatol Int 32:1933-8. 2012
  7. doi request reprint Digital amputation in systemic sclerosis: prevalence and clinical associations. A retrospective longitudinal study
    Paola Caramaschi
    Unita di Reumatologia, Policlinico G B Rossi, Piazzale Scuro, 37134 Verona, Italy
    J Rheumatol 39:1648-53. 2012
  8. pmc Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group
    Chingching Foocharoen
    Department of Rheumatology, Basel University, Burgfelderstrasse 101, Basel 4012, Switzerland
    Arthritis Res Ther 14:R37. 2012
  9. ncbi request reprint Evaluation of finger skin temperature in scleroderma patients cyclically treated with iloprost
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Policlinico G B Rossi, Verona, Italy
    Joint Bone Spine 73:57-61. 2006
  10. doi request reprint A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Policlinico G B Rossi, Piazzale Scuro, 37134, Verona, Italy
    Clin Rheumatol 28:807-13. 2009

Collaborators

Detail Information

Publications49

  1. doi request reprint Dramatic improvement of anti-SS-A/Ro-associated interstitial lung disease after immunosuppressive treatment
    Caramaschi Paola
    Unita di Reumatologia, AOUI, Policlinico G B Rossi, P le Scuro, 37134, Verona, Italy
    Rheumatol Int 36:1015-21. 2016
    ..This report may be useful in making therapeutic decisions in case of interstitial lung disease associated with anti-SS-A antibody. ..
  2. doi request reprint Adherence to recommendations for cervical and breast cancer screening in systemic sclerosis
    P Caramaschi
    Rheumatology Unit, Department of Medicine, University of Verona
    Reumatismo 66:264-9. 2015
    ..The significant adherence to guidelines may be due to the schedule adopted by the local health public service, which regularly invites eligible subjects by mail to undergo cancer screening at no charge...
  3. doi request reprint Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis
    Paola Caramaschi
    Rheumatology Unit, University of Verona, Verona, Italy
    Clin Rheumatol 33:77-82. 2014
    ..Longitudinal studies are needed to evaluate if decrease of abdominal fat would improve lung function. ..
  4. doi request reprint The co-occurrence of Hashimoto thyroiditis in primary Sjogren's syndrome defines a subset of patients with milder clinical phenotype
    Paola Caramaschi
    Rheumatology Unit, Department of Medicine, University of Verona, Verona, Italy
    Rheumatol Int 33:1271-5. 2013
    ..1-8.2 % of the cases, without reaching statistical significance. The association of HT in patients suffering from pSS defines a subset of patients with milder disease and normal C4 levels...
  5. doi request reprint Very low levels of vitamin D in systemic sclerosis patients
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    Clin Rheumatol 29:1419-25. 2010
    ..Further trials are awaited to determine whether vitamin D could represent a modifiable factor able to interfere with SSc evolution...
  6. doi request reprint Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost
    Paola Caramaschi
    Rheumatology Unit, Department of Medicine, Piazzale Scuro, 37134 Verona, Italy
    Rheumatol Int 32:1933-8. 2012
    ..With the limits of an observational study and in the absence of a control group, our experience suggests that prolonged cyclic iloprost therapy may limit the incidence/progression of severe digital and visceral SSc-vasculopathy...
  7. doi request reprint Digital amputation in systemic sclerosis: prevalence and clinical associations. A retrospective longitudinal study
    Paola Caramaschi
    Unita di Reumatologia, Policlinico G B Rossi, Piazzale Scuro, 37134 Verona, Italy
    J Rheumatol 39:1648-53. 2012
    ..To evaluate the prevalence of digital necrosis requiring surgical amputation in a single-center group of patients with systemic sclerosis (SSc) and to compare the characteristics of patients with and those without this severe complication...
  8. pmc Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group
    Chingching Foocharoen
    Department of Rheumatology, Basel University, Burgfelderstrasse 101, Basel 4012, Switzerland
    Arthritis Res Ther 14:R37. 2012
    ..Erectile dysfunction (ED) is common in men with systemic sclerosis (SSc) but the demographics, risk factors and treatment coverage for ED are not well known...
  9. ncbi request reprint Evaluation of finger skin temperature in scleroderma patients cyclically treated with iloprost
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Policlinico G B Rossi, Verona, Italy
    Joint Bone Spine 73:57-61. 2006
    ..To evaluate by computerized digital thermometry (CDT) the effect of cyclic iloprost infusions on finger skin temperature (FST) in scleroderma patients...
  10. doi request reprint A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Policlinico G B Rossi, Piazzale Scuro, 37134, Verona, Italy
    Clin Rheumatol 28:807-13. 2009
    ..A score reflecting the sum of these factors may be useful to predict the risk of developing ischemic DUs...
  11. doi request reprint Anti-TNFalpha blockers, autoantibodies and autoimmune diseases
    Paola Caramaschi
    Dipartimento di Medicina Clinica Sperimentale, Universita di Verona, Policlinico G B Rossi, Piazzale Scuro, 37134 Verona, Italy
    Joint Bone Spine 76:333-42. 2009
    ..Similarities and differences among infliximab, etanercept and adalimumab concerning induced autoimmune phenomena are underlined...
  12. ncbi request reprint Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    Rheumatol Int 27:649-54. 2007
    ..Nevertheless, the majority of patients resulted negative in spite of ANA positivity at high titres; the molecular target of ANA which develop after infliximab administration still remains to be identified...
  13. ncbi request reprint Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Istituto Medicina Interna B, Universita di Verona, Policlinico G B Rossi, P le Scuro, 37134, Verona, Italy
    Rheumatol Int 26:58-62. 2005
    ....
  14. ncbi request reprint Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    Rheumatol Int 26:209-14. 2006
    ..Both CRP and Blys do not seem to participate in this phenomenon. Other autoantibodies were detected in a few patients, but no case of onset of new autoimmune disorders was observed...
  15. ncbi request reprint Low levels of activated factor VII in systemic sclerosis
    Alessandro Volpe
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    J Thromb Thrombolysis 22:133-8. 2006
    ....
  16. ncbi request reprint Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: a case report
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Policlinico G B Rossi, P le Scuro, 37134 Verona, Italy
    Rheumatol Int 28:385-6. 2008
    ..The authors describe a young man suffering from systemic sclerosis who showed a dramatic progression of skin involvement after the appearance of anti-Scl70 antibody...
  17. doi request reprint Cyclophosphamide treatment improves microvessel damage in systemic sclerosis
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Policlinico G B Rossi, Piazzale Scuro, 37134 Verona, Italy
    Clin Rheumatol 28:391-5. 2009
    ..02). In our study, cyclophosphamide treatment demonstrated to be effective for scleroderma microvascular damage as directly observed by nailfold videocapillaroscopy...
  18. ncbi request reprint Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Policlinico GB Rossi, P le Scuro, 37134 Verona, Italy
    Rheumatol Int 27:203-5. 2006
    ....
  19. ncbi request reprint Correlation between homocysteine plasma levels and nailfold videocapillaroscopic patterns in systemic sclerosis
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Policlinico GB Rossi, P le Scuro, Verona, 37134, Italy
    Clin Rheumatol 26:902-7. 2007
    ..Hyperhomocysteinemia may represent an aggravating factor among the complex mechanisms involved in scleroderma damage contributing to the injury of endothelium...
  20. ncbi request reprint Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis
    Martina Montagnana
    Sezione di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico Biomediche, Universita degli Studi di Verona, Ospedale Policlinico G B Rossi, Piazzale Scuro, 10, Verona, Italy
    Clin Biochem 40:837-42. 2007
    ..This activity is controlled by tissue inhibitors of MMP (TIMPs). Aim of this study was the evaluation of MMP-9/TIMP-1 and MMP-2/TIMP-2 systems in patients with SSc...
  21. doi request reprint Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis
    Alessandro Volpe
    Dipartimento di Medicina Clinica Sperimentale, Policlinico G B Rossi, Piazzale Scuro, 37134, Verona, Italy
    Rheumatol Int 29:1073-9. 2009
    ..In particular high levels of anti-Scl70 antibodies are associated with a worse cutaneous involvement, while high levels of anti-CENP-B antibodies seem to have a protective effect on skin manifestations...
  22. ncbi request reprint Evaluation of cardiac laboratory markers in patients with systemic sclerosis
    Martina Montagnana
    Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico Biomediche, Universita degli Studi di Verona, Ospedale Policlinico G B Rossi, Verona, Italy
    Clin Biochem 39:913-7. 2006
    ..The aim of this study was the evaluation of the early subclinical cardiac involvement in patients with systemic sclerosis by means of non-invasive laboratory cardiac markers...
  23. ncbi request reprint Long-term evaluation of lung function in patients affected by scleroderma treated with cyclic iloprost infusions
    Paola Caramaschi
    Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
    Rheumatol Int 25:250-4. 2005
    ..The aim of this study was to evaluate pulmonary function in patients suffering from scleroderma treated for 3 years with cyclic iloprost infusions...
  24. doi request reprint Proteome analysis of biological fluids from autoimmune-rheumatological disorders
    Lucia De Franceschi
    Department of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy
    Proteomics Clin Appl 5:78-89. 2011
    ....
  25. ncbi request reprint [Homocysteine and rheumatic disease]
    Ilaria Tinazzi
    Dipartimento di Medicina Clinica e Sperimentale, Universita, Verona
    Recenti Prog Med 98:646-52. 2007
    ..Moreover it could contribute to explain the high incidence of cardiovascular events, than they do not find support in traditional risk factors...
  26. doi request reprint A study on thrombophilic factors in Italian Behcet's patients
    Paola Caramaschi
    Dipartimento di Medicina Clinica Sperimentale, Policlinico G B Rossi, Piazzale Scuro, 37134 Verona, Italy
    Joint Bone Spine 77:330-4. 2010
    ..Behcet's disease (BD) may complicate with arterial and venous thrombosis. The purpose of this work is to evaluate in an Italian group of BD patients with thrombotic events a large panel of inherited and acquired thrombophilic factors...
  27. ncbi request reprint Homocysteine plasma concentration is related to severity of lung impairment in scleroderma
    Paola Caramaschi
    Dipartmento di Medicina Clinica e Sperimentale, Policlinico GB Rossi, Verona, Italy
    J Rheumatol 30:298-304. 2003
    ..To investigate the correlation between plasma concentration of total homocysteine and pulmonary involvement in patients with limited or diffuse scleroderma (systemic sclerosis, SSc)...
  28. ncbi request reprint Coexistence of systemic sclerosis with other autoimmune diseases
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    Rheumatol Int 27:407-10. 2007
    ..Therefore patients with systemic sclerosis should be carefully evaluated both at onset and during the follow-up for the possible coexistence of other autoimmune disorders...
  29. ncbi request reprint Iloprost infusion does not reduce oxidative stress in systemic sclerosis
    Alessandro Volpe
    Department of Clinical and Experimental Medicine, University of Verona, P le LA Scuro 10, 37134, Verona, Italy
    Rheumatol Int 28:335-7. 2008
    ..Unlike experimental studies, in vivo the strong vasodilator effect of iloprost infusion did not reduce oxidative status...
  30. pmc Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H
    Cinzia Scambi
    Section of Rheumatology, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
    PLoS ONE 5:e12162. 2010
    ..Since the first cases, the similarity of ScGVHD to SSc has been reported. However, both diseases could have different etiopathogeneses. The objective of this study was to identify new serum biomarkers involved in SSc and ScGVHD...
  31. ncbi request reprint Psoriasis onset during infliximab treatment: description of two cases
    Alessandro Volpe
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    Rheumatol Int 26:1158-60. 2006
    ....
  32. ncbi request reprint Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, P le Scuro, 37134 Verona, Italy
    Clin Rheumatol 26:1795-6. 2007
    ..The authors describe a young patient affected by long-standing polymyositis refractory to conventional treatment who showed a rapid and striking response to mycophenolate mofetil treatment...
  33. ncbi request reprint Celiac disease in a rheumatology unit: a case study
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Policlinico G B Rossi, P le Scuro, 37134 Verona, Italy
    Rheumatol Int 28:547-51. 2008
    ..These confounding factors often lead to a delay in performing the right diagnostic formulation...
  34. doi request reprint Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis
    Cristian Caimmi
    Unita di Reumatologia, Policlinico G B Rossi, University of Verona, Piazzale Scuro, 37134, Verona, Italy
    Calcif Tissue Int 99:23-9. 2016
    ..037). We found a modest risk of low BMD in patients with SSc and the important protective role of BMI. Patients with lung involvement showed lower whole body Z score. ..
  35. pmc Plasma D-dimer concentration in patients with systemic sclerosis
    Giuseppe Lippi
    Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico Biomediche, Universita degli Studi di Verona, Verona, Italy
    Thromb J 4:2. 2006
    ..Little is known so far on the activation of the hemostatic and fibrinolytic systems in SSc, and most preliminary evidences are discordant...
  36. pmc The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study
    Cinzia Scambi
    Department of Medicine, University of Verona, Verona, Italy
    PLoS ONE 10:e0114856. 2015
    ..We also analyzed two polymorphic variants in the complement activation gene cluster involving the MCP region...
  37. ncbi request reprint [HLA-DRB1 alleles and rheumatoid arthritis in northern Italy: lack of correlation with disease severity and extra-articular manifestations]
    Ruggero Beri
    Sezione di Medicina Interna, Dipartimento di Medicina Clinica e Sperimentale, Policlinico G B Rossi, Universita di Verona
    Recenti Prog Med 96:139-43. 2005
    ..000047). No difference was observed for the presence of early erosions and extra-articular features in patients with no, one or two RA associated alleles and among share epitope positive and negative patients...
  38. ncbi request reprint [Neutrophils in rheumatoid inflammation]
    Domenico Biasi
    Dipartimento di Medicina Clinica e Sperimentale, Universita, Verona
    Recenti Prog Med 94:25-30. 2003
    ....
  39. ncbi request reprint [Erdheim-Chester disease]
    Paola Caramaschi
    Dipartimento di Medicina Clinica e Sperimentale, Universita, Verona
    Recenti Prog Med 95:104-7. 2004
    ....
  40. doi request reprint Familial hypocalciuric hypercalcemia revealed by chondrocalcinosis
    Alessandro Volpe
    Sacro Cuore Hospital, Department of Internal Medicine, and University of Verona, Department of Clinical and Experimental Medicine, Verona, Italy
    Joint Bone Spine 76:708-10. 2009
    ..The disease is caused by inactivating mutations in the calcium-sensing receptor gene...
  41. ncbi request reprint Clinical images: Neuropathic joint in a patient with calcium pyrophosphate deposition disease
    Paola Caramaschi
    University of Verona, Italy
    Arthritis Rheum 48:1170. 2003
  42. doi request reprint Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study
    Amelia Ruffatti
    Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Padua, Padua, Italy
    Ann Rheum Dis 70:1083-6. 2011
    ..To assess risk factors for a first thrombotic event in confirmed antiphospholipid (aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments...
  43. ncbi request reprint Lipoprotein[a] and the lipid profile in patients with systemic sclerosis
    Giuseppe Lippi
    Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico Biomediche, Universita degli Studi di Verona, Ospedale Policlinico G B Rossi, Piazzale Scuro, 10, 37134 Verona, Italy
    Clin Chim Acta 364:345-8. 2006
    ..Little is known so far on the lipid profile of these patients...
  44. doi request reprint Multineuropathy in a patient with HBV infection, polyarteritis nodosa and celiac disease
    Giovanna Squintani
    Department of Neurological Sciences, University of Verona, Verona, Italy
    Rheumatol Int 29:579-81. 2009
    ..Celiac disease can be related to a higher risk of autoimmune disorders and may have contributed to the development of multineuropathy in this patient...
  45. doi request reprint Ultrasound evaluation of ulnar neuropathy at the elbow: correlation with electrophysiological studies
    Alessandro Volpe
    Department of Internal Medicine, Sacro Cuore Hospital, Verona, Italy
    Rheumatology (Oxford) 48:1098-101. 2009
    ..To evaluate, in patients with ulnar neuropathy at the elbow (UNE), if ultrasonographic differences in ulnar nerve size correlate with severity score determined by electrodiagnostic studies...
  46. ncbi request reprint Pancreatic granulomatous necrotizing vasculitis: a case report and review of the literature
    Ilaria Tinazzi
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Verona, Verona, Italy
    Rheumatol Int 27:989-91. 2007
    ..No other visceral involvement was found; test for antineutrophil cytoplasmic antibodies was negative. Initial and symptomatic involvement of pancreas was reported in very few cases of WG...
  47. ncbi request reprint [Infliximab in aggressive and refractory rheumatoid arthritis. A pilot study]
    Paola Caramaschi
    Cattedra di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Universita, Verona
    Recenti Prog Med 93:19-24. 2002
    ..Rheumatoid arthritis may be not responsive to the common second line drugs. This study was aimed to treat 15 patients affected by severe refractory rheumatoid arthritis with infliximab...
  48. ncbi request reprint Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection
    Achille Ambrosetti
    Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy
    Br J Haematol 126:43-9. 2004
    ..The close association of SGML with either autoimmune diseases or HCV infection in our series (73%) confirms their possible role in the pathogenesis of these lymphomas...